Skip to main content
Premium Trial:

Request an Annual Quote

OriGene Raises $21.3M in Series C Funding

NEW YORK (GenomeWeb News) – OriGene Technologies today announced the completion of its $21.3 million Series C financing round.

Qiming Venture Partners and Kleiner Perkins Caufield Byers China led the round, while existing investor IDG-Accel also participated, OriGene said.

The company intends to use the financing to "advance our growth strategy and operations," Wei-Wu He, OriGene's chairman and CEO, said in a statement, without elaborating.

Based in Rockville, Md., the company develops genomic research and diagnostic products. Its flagship product is the cDNA clone collection, a searchable gene bank with more than 30,000 human full-length TrueClone cDNA collections and more than 25,000 TrueORF cDNA clones, it said on its website.

Additionally, the company has developed "ultra-sensitive" monoclonal antibodies called UltraMAB.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.